In line with these animal data, treatment with monacolin K induced a significant decrease in the HOMA-index of our NAFLD patients, supporting the hypothesis of a possible benefit on insulin sensitivity. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.